Keynote
AI is learning the language of cells. Nina maps the convergence of machine intelligence and living systems — from algorithm-designed tissues to biology as the next computing platform — and what it means for every industry that touches the human body.
Machine intelligence and living systems are converging faster than most industries realize. Algorithms now help design the conditions that grow EpiBone's living bone grafts; protein-folding models are compressing decades of biology into months; and cells themselves are being programmed like circuits. Nina has worked on both sides of this convergence — she started her career engineering telecom networks before she ever engineered tissue — and she makes the collision vivid, concrete, and navigable.
This talk gives audiences a working map of the AI-biology frontier: where the breakthroughs are real, where the hype outruns the science, and how organizations far outside the lab — insurers, manufacturers, investors, software companies — will feel the impact. Audiences leave with a new mental model: intelligence as something we can grow as well as build.
Watch
The future of repairing the human body
TED2023 — Live from the TED2023 mainstage in Vancouver
Could tissue engineering mean personalized medicine?
TEDGlobal — Over one million views
More keynotes
What happens when replacement parts for the human body become real, and they are grown from your own cells? Drawing on the first human trials of lab-grown bone, Nina charts the path from one-size-fits-all healthcare to treatments as personal as a fingerprint, and from living longer to living fully: lifespan, healthspan, and what she calls joyspan.
For
Cells are becoming partners in design: self-healing bridges, living textiles, lab-grown bone and meat. Nina shows how growing products will transform materials, medicine, and supply chains, and what it takes to grow living products safely and at home: the biomanufacturing capacity, the safeguards, and the policy choices behind a secure bioeconomy.
For
Living bone grown from a patient's own cells was science fiction a decade ago. Today it is in human trials. Nina shares what it took to get there, from lab bench to FDA-cleared clinical trials: building teams, culture, and conviction for a product that is alive, and the lessons that transfer to anyone building something the world calls impossible.
For
Patients research, organize, invest, and demand better. Drawing on a decade of getting EpiBone's first patient to the operating room and the emails that kept arriving, Nina charts how people in pain became partners in medicine: as advocates, as investors through crowdfunding, and as participants claiming the right to try.
For
From TED to Davos, Nina translates the frontier of biology and technology into talks audiences never forget.
Keynotes are booked through The Lavin Agency. Interviews, podcasts, and campus or community talks come straight to Nina's team.